Hai-Di Li

2.1k total citations
50 papers, 1.6k citations indexed

About

Hai-Di Li is a scholar working on Molecular Biology, Epidemiology and Nephrology. According to data from OpenAlex, Hai-Di Li has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Epidemiology and 14 papers in Nephrology. Recurrent topics in Hai-Di Li's work include Liver Disease Diagnosis and Treatment (15 papers), Chronic Kidney Disease and Diabetes (9 papers) and Alcohol Consumption and Health Effects (9 papers). Hai-Di Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Chronic Kidney Disease and Diabetes (9 papers) and Alcohol Consumption and Health Effects (9 papers). Hai-Di Li collaborates with scholars based in China, Hong Kong and Saint Kitts and Nevis. Hai-Di Li's co-authors include Xiao‐Ming Meng, Jun Li, Li Gao, Weifeng Wu, Cheng Huang, Qin Yang, Xiongwen Lv, Cheng Huang, Haiyong Chen and Gui‐Ling Ren and has published in prestigious journals such as Hepatology, Oncogene and The FASEB Journal.

In The Last Decade

Hai-Di Li

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hai-Di Li China	25	736	369	323	317	220	50	1.6k
Guixia Ding China	25	937 1.3×	633 1.7×	178 0.6×	278 0.9×	192 0.9×	68	2.0k
Anil Bhanudas Gaikwad India	29	908 1.2×	516 1.4×	224 0.7×	169 0.5×	156 0.7×	110	2.3k
Shaogui Wang China	28	1.0k 1.4×	165 0.4×	875 2.7×	411 1.3×	186 0.8×	45	2.3k
Yanggang Yuan China	26	1.1k 1.5×	771 2.1×	345 1.1×	267 0.8×	157 0.7×	86	2.3k
Dongdong Yuan China	23	703 1.0×	116 0.3×	161 0.5×	156 0.5×	149 0.7×	60	1.4k
Wei Cao China	21	602 0.8×	263 0.7×	254 0.8×	158 0.5×	139 0.6×	70	1.6k
Anne‐Émilie Declèves Belgium	24	708 1.0×	449 1.2×	269 0.8×	141 0.4×	113 0.5×	50	2.0k
Rongshuang Huang China	18	572 0.8×	447 1.2×	168 0.5×	109 0.3×	106 0.5×	34	1.3k
Xiaoxin X. Wang United States	22	657 0.9×	396 1.1×	480 1.5×	113 0.4×	92 0.4×	39	2.1k

Countries citing papers authored by Hai-Di Li

Since Specialization

Citations

This map shows the geographic impact of Hai-Di Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai-Di Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai-Di Li more than expected).

Fields of papers citing papers by Hai-Di Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai-Di Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai-Di Li. The network helps show where Hai-Di Li may publish in the future.

Co-authorship network of co-authors of Hai-Di Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hai-Di Li. A scholar is included among the top collaborators of Hai-Di Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai-Di Li. Hai-Di Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Hai-Di, Miao Cheng, Li Sun, et al.. (2025). BRD2 promotes inflammation and lipid accumulation through the NF-κB pathway in alcoholic liver injury. Biochemical Pharmacology. 243(Pt 1). 117442–117442.

Wang, Yifan, Yong‐Ke You, Jianbo Guo, et al.. (2024). C-reactive protein promotes diabetic kidney disease via Smad3-mediated NLRP3 inflammasome activation. Molecular Therapy. 33(1). 263–278. 3 indexed citations

Liu, Chen, Yifan Wang, Hui Zhang, et al.. (2024). Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. EClinicalMedicine. 69. 102482–102482. 11 indexed citations

Li, Hai-Di, Xin Chen, Jiejie Xu, et al.. (2023). GRP/GRPR enhances alcohol-associated liver injury through the IRF1-mediated Caspase-1 inflammasome and NOX2-dependent ROS pathway. Hepatology. 79(2). 392–408. 21 indexed citations

Zhu, Lin, Jiejie Xu, Hai-Di Li, et al.. (2023). Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate–Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease. Laboratory Investigation. 103(4). 100041–100041. 12 indexed citations

Li, Huashan, Hui Zhang, Yifan Wang, et al.. (2023). Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism. Frontiers in Cardiovascular Medicine. 9. 1090616–1090616. 6 indexed citations

Li, Hai-Di, Yong‐Ke You, Weifeng Wu, et al.. (2022). Roles and crosstalks of macrophages in diabetic nephropathy. Frontiers in Immunology. 13. 1015142–1015142. 77 indexed citations

Xu, Jiejie, Lin Zhu, Hai-Di Li, et al.. (2022). DNMT3a-mediated methylation of PSTPIP2 enhances inflammation in alcohol-induced liver injury via regulating STAT1 and NF-κB pathway. Pharmacological Research. 177. 106125–106125. 13 indexed citations

Sun, Ying-Yin, Lei Yang, Xin Chen, et al.. (2021). Arrb2 causes hepatic lipid metabolism disorder via AMPK pathway based on metabolomics in alcoholic fatty liver. Clinical Science. 135(10). 1213–1232. 12 indexed citations

10.

Xu, Jiejie, Hai-Di Li, Juanjuan Li, et al.. (2021). Role of the F-BAR Family Member PSTPIP2 in Autoinflammatory Diseases. Frontiers in Immunology. 12. 585412–585412. 15 indexed citations

11.

Wu, Weifeng, Yifan Wang, Hai-Di Li, Haiyong Chen, & Jiangang Shen. (2021). Buyang Huanwu Decoction protects against STZ-induced diabetic nephropathy by inhibiting TGF-β/Smad3 signaling-mediated renal fibrosis and inflammation. Chinese Medicine. 16(1). 118–118. 26 indexed citations

12.

Li, Chao, Ying Chen, Yuan He, et al.. (2021). The Programmed Cell Death of Macrophages, Endothelial Cells, and Tubular Epithelial Cells in Sepsis-AKI. Frontiers in Medicine. 8. 796724–796724. 53 indexed citations

13.

Zhang, Shao‐Fei, et al.. (2021). Epigenetics and Inflammation in Diabetic Nephropathy. Frontiers in Physiology. 12. 649587–649587. 39 indexed citations

14.

Yu, Ju-tao, Xiaowei Hu, Haiyong Chen, et al.. (2020). DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-α in alcohol-induced kidney injury. Pharmacological Research. 163. 105286–105286. 64 indexed citations

15.

Li, Hai-Di, Xin Chen, Jiejie Xu, et al.. (2020). DNMT3b-mediated methylation of ZSWIM3 enhances inflammation in alcohol-induced liver injury via regulating TRAF2-mediated NF-κB pathway. Clinical Science. 134(14). 1935–1956. 22 indexed citations

16.

Wang, Jianan, Biao Wei, Juan Jin, et al.. (2020). 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation. Phytomedicine. 69. 153202–153202. 42 indexed citations

17.

Chen, Xin, Hai-Di Li, Fangtian Bu, et al.. (2020). Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics. 10(11). 4851–4870. 68 indexed citations

18.

Li, Wanxia, Xin Chen, Yang Yang, et al.. (2016). Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway. Toxicology. 381. 75–86. 24 indexed citations

19.

Gao, Li, Weifeng Wu, Gui‐Ling Ren, et al.. (2016). Protocatechuic Aldehyde Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Nox-Mediated Oxidative Stress and Renal Inflammation. Frontiers in Pharmacology. 7. 479–479. 79 indexed citations

20.

Meng, Xiao‐Ming, Gui‐Ling Ren, Li Gao, et al.. (2016). Anti-fibrotic effect of wogonin in renal tubular epithelial cells via Smad3-dependent mechanisms. European Journal of Pharmacology. 789. 134–143. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact